Correlation Between Cidara Therapeutics and Enveric Biosciences
Can any of the company-specific risk be diversified away by investing in both Cidara Therapeutics and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cidara Therapeutics and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cidara Therapeutics and Enveric Biosciences, you can compare the effects of market volatilities on Cidara Therapeutics and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cidara Therapeutics with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cidara Therapeutics and Enveric Biosciences.
Diversification Opportunities for Cidara Therapeutics and Enveric Biosciences
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cidara and Enveric is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Cidara Therapeutics and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Cidara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cidara Therapeutics are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Cidara Therapeutics i.e., Cidara Therapeutics and Enveric Biosciences go up and down completely randomly.
Pair Corralation between Cidara Therapeutics and Enveric Biosciences
Given the investment horizon of 90 days Cidara Therapeutics is expected to generate 0.49 times more return on investment than Enveric Biosciences. However, Cidara Therapeutics is 2.04 times less risky than Enveric Biosciences. It trades about -0.13 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.54 per unit of risk. If you would invest 2,488 in Cidara Therapeutics on November 9, 2024 and sell it today you would lose (365.00) from holding Cidara Therapeutics or give up 14.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cidara Therapeutics vs. Enveric Biosciences
Performance |
Timeline |
Cidara Therapeutics |
Enveric Biosciences |
Cidara Therapeutics and Enveric Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cidara Therapeutics and Enveric Biosciences
The main advantage of trading using opposite Cidara Therapeutics and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cidara Therapeutics position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.Cidara Therapeutics vs. CytomX Therapeutics | Cidara Therapeutics vs. Clearside Biomedical | Cidara Therapeutics vs. GlycoMimetics |
Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |